Abstract

Low-energy x-rays are increasingly being used for intraoperative radiotherapy within and outside controlled trials. The Photon Radiosurgery System (PRS) is a miniaturized x-ray machine producing an essentially isotropic field of 30–50 kV x-rays. This device delivers a highly localized dose distribution and has been used for interstitial tumour irradiation and tumour-bed irradiation in different sites, including brain, abdomen and breast. However, prediction of the biological effect of such treatments is not straightforward because the increased relative biological effectiveness (RBE) of low-energy photons is influenced by the strong variation of dose associated with the non-uniform field and by repair during irradiation which may take up to 0.5–1 hour.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.